Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 112,720 | 53,010 | 19,170 | -84,620 | N/A |
| Depreciation Amortization | 4,735 | 0 | 0 | 0 | N/A |
| Accounts receivable | -13,385 | N/A | N/A | N/A | N/A |
| Other Working Capital | -80,120 | -39,530 | -42,770 | 30,310 | N/A |
| Other Operating Activity | 22,394 | 10,170 | 810 | 66,560 | 0 |
| Operating Cash Flow | $46,344 | $23,650 | $-22,790 | $12,250 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -51,410 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,405 | -2,150 | 7,990 | -1,440 | N/A |
| Purchase Sale Intangibles | -18,741 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -18,741 | -178,040 | 3,930 | -70,500 | 0 |
| Investing Cash Flow | $-71,555 | $-180,190 | $11,920 | $-71,940 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 95,727 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -35 | 184,600 | 27,010 | 61,830 | 0 |
| Financing Cash Flow | $95,692 | $184,600 | $27,010 | $61,830 | $N/A |
| Exchange Rate Effect | 6,137 | 5,980 | -260 | -480 | N/A |
| Beginning Cash Position | 53,432 | 29,970 | 14,060 | 11,990 | N/A |
| End Cash Position | 130,049 | 64,020 | 29,940 | 13,650 | N/A |
| Net Cash Flow | $76,617 | $34,040 | $15,870 | $1,650 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 46,344 | 23,650 | -22,790 | 12,250 | N/A |
| Capital Expenditure | -1,405 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 44,938 | 23,650 | -22,790 | 12,250 | 0 |